Literature DB >> 1433521

Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.

P Bagnarelli1, S Menzo, A Valenza, A Manzin, M Giacca, F Ancarani, G Scalise, P E Varaldo, M Clementi.   

Abstract

Recent molecular evidence indicates that active human immunodeficiency virus type 1 (HIV-1) infection is detectable in both symptomless and symptomatic infected patients. For this main reason, it has been pointed out that precise quantitative analysis of viral activity in vivo is necessary, firstly, for the pathogenetic investigation of the steps relevant to infection progression and, secondly, for better clinical management of HIV-1-infected patients. In this study, the presence of HIV-1 genomic RNA in plasma samples, specific HIV-1 transcripts in peripheral blood mononuclear cells, and proviral DNA sequences were assayed for 33 HIV-1-infected patients (including symptomless and symptomatic subjects) by using a competitive polymerase chain reaction method that allows quantitation of the RNA/DNA target sequences. The quantitative results obtained confirm that transcription of HIV-1 structural genes and complete viral replication occur in all the HIV-1-infected patients independently of the clinical stage. However, although sharp individual differences were detected, a high degree of correlation of the molecular parameters studied with both disease progression and a decrease in the number of CD4+ T lymphocytes was documented. Interestingly, despite the increasing viremia level associated with infection progression, the mean transcriptional activity of individual infected cells was found to be only moderately greater in AIDS patients than in asymptomatic infected subjects. In addition, it was noted that quantitation of HIV-1 genomic RNA in plasma samples and quantitation of specific HIV-1 transcripts in peripheral blood mononuclear cells appear to be more reliable and sensitive markers of viral activity than quantitative analysis of proviral HIV-1 sequences in peripheral lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433521      PMCID: PMC240437     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.

Authors:  M H Malim; D F McCarn; L S Tiley; B R Cullen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction.

Authors:  S Menzo; P Bagnarelli; M Giacca; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

3.  Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Authors:  S Delassus; R Cheynier; S Wain-Hobson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.

Authors:  N L Michael; M Vahey; D S Burke; R R Redfield
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

6.  Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates.

Authors:  M W Cloyd; B E Moore
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

7.  Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction.

Authors:  P Bagnarelli; S Menzo; A Manzin; P E Varaldo; M Montroni; M Giacca; M Clementi
Journal:  J Virol Methods       Date:  1991-04       Impact factor: 2.014

8.  Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction.

Authors:  P Bagnarelli; S Menzo; A Manzin; M Giacca; P E Varaldo; M Clementi
Journal:  J Med Virol       Date:  1991-06       Impact factor: 2.327

9.  Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.

Authors:  R Balachandran; P Thampatty; A Enrico; C Rinaldo; P Gupta
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

10.  Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection.

Authors:  J Albert; H Gaines; A Sönnerborg; G Nyström; P O Pehrson; F Chiodi; M von Sydow; L Moberg; K Lidman; B Christensson
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

View more
  37 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR.

Authors:  M G Revello; F Baldanti; A Sarasini; M Zavattoni; M Torsellini; G Gerna
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction.

Authors:  G Grassi; L Zentilin; S Tafuro; S Diviacco; A Ventura; A Falaschi; M Giacca
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

6.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

Authors:  G Pantaleo; J F Demarest; T Schacker; M Vaccarezza; O J Cohen; M Daucher; C Graziosi; S S Schnittman; T C Quinn; G M Shaw; L Perrin; G Tambussi; A Lazzarin; R P Sekaly; H Soudeyns; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 8.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

9.  Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.

Authors:  M Adams; L Sharmeen; J Kimpton; J M Romeo; J V Garcia; B M Peterlin; M Groudine; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.

Authors:  P Bagnarelli; S Menzo; A Valenza; S Paolucci; S Petroni; G Scalise; R Sampaolesi; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.